Azerbaijan vs Eritrea: HIV/AIDS deaths averted by antiretroviral therapy
Azerbaijan
607.42 deaths
in 2024
Eritrea
540.91 deaths
in 2024
Azerbaijan rank
87th
Eritrea rank
89th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Azerbaijan
- Eritrea
How they compare
Azerbaijan currently reports 607.42 deaths against 540.91 deaths in Eritrea, a difference of 66.51 deaths.
That makes Azerbaijan's figure about 1.1 times Eritrea's.
The two have swapped places 3 times across 35 shared years of data; in 1990 it was Eritrea ahead.
Azerbaijan ranks 87th and Eritrea ranks 89th of 157 countries.
Eritrea has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Azerbaijan | Eritrea | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 12.14 deaths | 233.34 deaths | 221.2 deaths | Eritrea |
| 2010s | 273.78 deaths | 817.66 deaths | 543.88 deaths | Eritrea |
| 2020s | 561.31 deaths | 588.52 deaths | 27.22 deaths | Eritrea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Azerbaijan or Eritrea?
- Azerbaijan, at 607.42 deaths against 540.91 deaths in Eritrea as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Azerbaijan and Eritrea?
- 66.51 deaths, with Azerbaijan ahead.
- How many years of comparable data are there for Azerbaijan and Eritrea?
- 35 years are reported by both, from 1990 to 2024.
- How do Azerbaijan and Eritrea rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Azerbaijan ranks 87th and Eritrea ranks 89th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.